Halozyme Therapeutics Inc. Common Stock vs PDD Holdings Inc. American Depositary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while PDD Holdings Inc. American Depositary Shares trades at $81.38 (market cap $111.40B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 8.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, PDD Holdings Inc. American Depositary Shares nearer its low. Which is the better fit depends on your goals.
| HALO | PDD | |
|---|---|---|
Market Cap | $12.58B | $111.40B |
Volume | 2,179,278 | 4,823,275 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $138.13 |
52-Week Low | $61.63 | $73.30 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $14.49B | $44.04B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.
Read more on PDD →